Patient-specific pluripotent stem cells in neurological diseases.
about
Reprogramming with Small Molecules instead of Exogenous Transcription FactorsStimulus information stored in lasting active and hidden network states is destroyed by network bursts.Connectivity and circuitry in a dish versus in a brainThe adverse effects of air pollution on the nervous system.Modeling Ischemic Stroke In Vitro: Status Quo and Future Perspectives.Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients.Progress in stem cell therapy for major human neurological disorders.Induced pluripotent stem cells and their implication for regenerative medicine.The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders.Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosisIsolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta.Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted ScaffoldStem cells in drug screening for neurodegenerative disease.Stem cells as in vitro model of Parkinson's disease.Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks.3-D Bioprinting of Neural Tissue for Applications in Cell Therapy and Drug Screening.A Novel Protocol to Differentiate Induced Pluripotent Stem Cells by Neuronal microRNAs to Provide a Suitable Cellular Model.Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells.
P2860
Q28084394-99022670-7B47-4931-A752-8FEB2ADB0D14Q35110490-CFE13A3A-74D6-4335-B997-340A5C4E01B4Q35684598-2DE093D8-7D39-48A3-85E9-807AFEF447B6Q35864850-84FCA2F6-E4EE-4E57-86E0-FC7040BA2993Q36510263-6DD31D18-2AEF-4A3A-924E-316357226A5FQ37663637-7158652C-19A1-4F56-9712-BC4ACCC06970Q38107439-4DB588D3-98B3-4AF8-B4BC-4D0C0ED2278EQ38231103-4908E5B4-FE94-46F8-B55D-D1096D0E4774Q39030396-54203B95-BE0A-45D6-819F-5390B5500154Q40884175-F6CC943E-A150-4364-8B89-93D19FC4CA88Q41470324-4CC2BE36-D47D-4EA3-B617-78E1071DECB5Q41660266-1ADD1917-EDE2-4E44-947B-624AD57989FFQ42038314-4E3EA64B-F33A-4228-979E-AE4B628E1607Q42159528-E9974D98-772A-4B4F-9728-512A2DD570BDQ42577149-334B3692-D7BB-457B-95B5-66CBDB002C83Q45913223-2595EB99-3C21-4335-B573-756D8370CFA3Q48445205-90ACD5DA-D814-4ED0-A9E4-E44E24E2FBC8Q50848812-8849D9F6-EAE5-4182-98A6-0388F354C6AD
P2860
Patient-specific pluripotent stem cells in neurological diseases.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Patient-specific pluripotent stem cells in neurological diseases.
@en
type
label
Patient-specific pluripotent stem cells in neurological diseases.
@en
prefLabel
Patient-specific pluripotent stem cells in neurological diseases.
@en
P2093
P2860
P356
P1476
Patient-specific pluripotent stem cells in neurological diseases.
@en
P2093
Kursad Genc
Sermin Genc
Serpen Durnaoglu
P2860
P304
P356
10.4061/2011/212487
P577
2011-07-03T00:00:00Z